Keryx Biopharmaceuticals (KERX) March and June volatility Skewed higher at 179

January 2, 2008 9:03 AM EST Send to a Friend
Keryx Biopharmaceuticals (Nasdaq: KERX) : KERX lead compound, Sulonex (sulodexide oral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login